{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:22:06Z","timestamp":1783336926448,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Halle (Saale)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Children and adolescents with classical Hodgkin lymphoma have a progression-free survival (PFS) rate of \u2265\u200990% with current treatments. The current challenge is to reduce adverse late-effects while maintaining high survival. Distinguishing lung involvement (Stage IV) from benign lung lesions remains a staging challenge in pediatric Hodgkin lymphoma (pHL). This study analyzed the prevalence, morphological patterns, and prognostic impact of lung lesions on progression-free survival (PFS) within the EuroNet-PHL-C1 trial. A retrospective analysis was conducted on chest CT scans from 1,298 pHL patients enrolled in the EuroNet-PHL-C1 trial. Patients were stratified by established treatment groups (TG-1, TG-2, TG-3). Lesions were classified by morphological pattern, and Kaplan-Meier analysis was used to compare 60-month PFS between groups with and without lung lesions. Lung lesions were identified in 60.2% (782\/1298) of patients, with nodules being the predominant pattern (89%). In the combined TG-1 and TG-2 cohort (early\/intermediate stages), the presence of any lung lesion correlated with significantly lower 5-year PFS (85.5% vs. 91.7%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0197). Importantly, this lower PFS was driven by non-nodule morphologies. In the TG-3 (advanced stage) cohort, neither the presence of lung lesions nor stage IV classification significantly affected PFS. Lung lesions are highly prevalent in pHL. However, the presence of pulmonary nodules does not confer an inferior prognosis. The prognostic impact of lung lesions is primarily limited to non-nodule patterns in early-stage disease. These findings suggest that incorporating morphological patterns may be beneficial for refining risk stratification in future pHL trials.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-60214-5","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:47:12Z","timestamp":1783331232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Jonas","family":"Steglich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auke","family":"Beishuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Cepelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez-Teijeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie E.","family":"Flerlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hasenclever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hraskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klekawka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"K\u00f6rholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Landman-Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mauz-K\u00f6rholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Uyttebroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vordermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Hamish","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A.","family":"Wohlgemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-4488","authenticated-orcid":false,"given":"Dietrich","family":"Stoevesandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"60214_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2008-1026870","volume":"198","author":"G Schellong","year":"1986","unstructured":"Schellong, G. et al. Kombinierte Behandlungsstrategie bei \u00fcber 200 Kindern mit Morbus Hodgkin: Abgestufte Chemotherapie, Involved-Field-Bestrahlung mit erniedrigten Dosen und selektive Splenektomie. Ein Bericht der kooperativen Therapiestudie DAL-HD-82. Klin. Padiatr. 198, 137\u2013146 (1986).","journal-title":"Klin. Padiatr"},{"key":"60214_CR2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1200\/JCO.1997.15.8.2769","volume":"15","author":"MA Weiner","year":"1997","unstructured":"Weiner, M. A. et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin\u2019s disease in pediatric patients: a Pediatric Oncology Group study. J. Clin. Oncol. 15, 2769\u20132779 (1997).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR3","first-page":"3736","volume":"17","author":"G Schellong","year":"1999","unstructured":"Schellong, G. et al. High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin\u2019s Disease: The German-Austrian Multicenter Trial DAL-HD-90. J. Clin. Orthod. 17, 3736\u20133744 (1999).","journal-title":"J. Clin. Orthod."},{"key":"60214_CR4","first-page":"3081","volume":"20","author":"SS Donaldson","year":"2002","unstructured":"Donaldson, S. S. et al. VAMP and Low-Dose, Involved-Field Radiation for Children and Adolescents With Favorable, Early-Stage Hodgkin\u2019s Disease: Results of a Prospective Clinical Trial. J. Clin. Orthod. 20, 3081\u20133087 (2002).","journal-title":"J. Clin. Orthod."},{"key":"60214_CR5","doi-asserted-by":"crossref","unstructured":"Schwartz, C. L. et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood 114, 2051\u20132059 (2009).","DOI":"10.1182\/blood-2008-10-184143"},{"key":"60214_CR6","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","volume":"32","author":"DL Friedman","year":"2014","unstructured":"Friedman, D. L. et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children\u2019s Oncology Group Study AHOD0031. J. Clin. Oncol. 32, 3651\u20133658 (2014).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1470-2045(21)00470-8","volume":"23","author":"C Mauz-K\u00f6rholz","year":"2022","unstructured":"Mauz-K\u00f6rholz, C. et al. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 23, 125\u2013137 (2022).","journal-title":"Lancet Oncol."},{"key":"60214_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S1470-2045(23)00019-0","volume":"24","author":"C Mauz-K\u00f6rholz","year":"2023","unstructured":"Mauz-K\u00f6rholz, C. et al. Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study. Lancet Oncol. 24, 252\u2013261 (2023).","journal-title":"Lancet Oncol."},{"key":"60214_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ijc.2910390506","volume":"39","author":"JM Kaldor","year":"1987","unstructured":"Kaldor, J. M. et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin\u2019s disease: an international collaborative study among cancer registries. Int. J. Cancer. 39, 571\u2013585 (1987).","journal-title":"Int. J. Cancer"},{"key":"60214_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJM199603213341201","volume":"334","author":"S Bhatia","year":"1996","unstructured":"Bhatia, S. et al. Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease. N Engl. J. Med. 334, 745\u2013751 (1996).","journal-title":"N Engl. J. Med."},{"key":"60214_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/pbc.22664","volume":"55","author":"G Schellong","year":"2010","unstructured":"Schellong, G. et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr. Blood Cancer. 55, 1145\u20131152 (2010).","journal-title":"Pediatr. Blood Cancer"},{"key":"60214_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00408-012-9418-4","volume":"191","author":"EM Ibrahim","year":"2013","unstructured":"Ibrahim, E. M. et al. Increased risk of second lung cancer in Hodgkin\u2019s lymphoma survivors: a meta-analysis. Lung 191, 117\u2013134 (2013).","journal-title":"Lung"},{"key":"60214_CR13","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","volume":"129","author":"FA van Nimwegen","year":"2017","unstructured":"van Nimwegen, F. A. et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood 129, 2257\u20132265 (2017).","journal-title":"Blood"},{"key":"60214_CR14","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. & Tubiana, M. Report of the Committee on Hodgkin\u2019s Disease Staging Classification. Cancer Res. 31, 1860\u20131861 (1971).","journal-title":"Cancer Res."},{"key":"60214_CR15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister, T. A. et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J. Clin. Oncol. 7, 1630\u20131636 (1989).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR16","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson, B. D. et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J. Clin. Oncol. 32, 3059\u20133068 (2014).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR17","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington, S. F. et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J. Clin. Oncol. 32, 3048\u20133058 (2014).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR18","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","volume":"33","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz, C. et al. Pediatric Hodgkin Lymphoma. J. Clin. Oncol. 33, 2975\u20132985 (2015).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00975311","volume":"5","author":"BA Kolygin","year":"1976","unstructured":"Kolygin, B. A. & Vesnin, A. G. Hodgkin\u2019s disease in children: involvement of lung and pleura. Pediatr. Radiol. 5, 75\u201380 (1976).","journal-title":"Pediatr. Radiol."},{"key":"60214_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1148\/120.2.277","volume":"120","author":"R Filly","year":"1976","unstructured":"Filly, R., Bland, N. & Castellino, R. A. Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Radiology 120, 277\u2013281 (1976).","journal-title":"Radiology"},{"key":"60214_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/thx.32.6.664","volume":"32","author":"JB MacDonald","year":"1977","unstructured":"MacDonald, J. B. Lung involvement in Hodgkin\u2019s disease. Thorax 32, 664\u2013667 (1977).","journal-title":"Thorax"},{"key":"60214_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0037-198X(80)90049-8","volume":"15","author":"N Blank","year":"1980","unstructured":"Blank, N. & Castellino, R. A. The intrathoracic manifestations of the malignant lymphomas and the leukemias. Semin Roentgenol. 15, 227\u2013245 (1980).","journal-title":"Semin Roentgenol."},{"key":"60214_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00247-003-1080-9","volume":"34","author":"KE Maturen","year":"2004","unstructured":"Maturen, K. E., Blane, C. E., Strouse, P. J. & Fitzgerald, J. T. Pulmonary involvement in pediatric lymphoma. Pediatr. Radiol. 34, 120\u2013124 (2004).","journal-title":"Pediatr. Radiol."},{"issue":"Suppl 2","key":"60214_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/2047-783X-15-S2-206","volume":"15","author":"T Urasinski","year":"2010","unstructured":"Urasinski, T. et al. Pediatric pulmonary Hodgkin lymphoma: analysis of 10 years data from a single center. Eur. J. Med. Res. 15 (Suppl 2), 206\u2013210 (2010).","journal-title":"Eur. J. Med. Res."},{"key":"60214_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.HS9.0000890928.50034.5f","volume":"6","author":"J Seelisch","year":"2022","unstructured":"Seelisch, J. et al. P090: Staging of Lung Lesions Survey Demonstrates Continued Need for Harmonization. HemaSphere 6, 41 (2022).","journal-title":"HemaSphere"},{"key":"60214_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/hon.3163_37","volume":"41","author":"J Seelisch","year":"2023","unstructured":"Seelisch, J. et al. Lung staging in pediatric Hodgkin lymphoma: Staging evaluation & response criteria harmonization for childhood, adolescent & young adult hl (search for cayahl) consensus. Hematol. Oncol. 41, 71\u201373 (2023).","journal-title":"Hematol. Oncol."},{"key":"60214_CR27","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00247-017-3946-2","volume":"47","author":"A Samim","year":"2017","unstructured":"Samim, A. et al. Frequency and characteristics of pulmonary nodules in children at computed tomography. Pediatr. Radiol. 47, 1751\u20131758 (2017).","journal-title":"Pediatr. Radiol."},{"key":"60214_CR28","doi-asserted-by":"crossref","unstructured":"Flerlage, J. E. et al. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement. Pediatr Blood Cancer 64, (2017).","DOI":"10.1002\/pbc.26421"},{"key":"60214_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00259-003-1375-y","volume":"31","author":"LS Freudenberg","year":"2004","unstructured":"Freudenberg, L. S. et al. FDG-PET\/CT in re-staging of patients with lymphoma. Eur. J. Nucl. Med. Mol. Imaging. 31, 325\u2013329 (2004).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"60214_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1148\/radiol.2323030985","volume":"232","author":"NG Schaefer","year":"2004","unstructured":"Schaefer, N. G. et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging\u2013do we need contrast-enhanced CT? Radiology 232, 823\u2013829 (2004).","journal-title":"Radiology"},{"key":"60214_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.mibio.2004.08.004","volume":"6","author":"M Allen-Auerbach","year":"2004","unstructured":"Allen-Auerbach, M. et al. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography\/computed tomography hardware fusion for staging of patients with lymphoma. Mol. Imaging Biol. 6, 411\u2013416 (2004).","journal-title":"Mol. Imaging Biol."},{"issue":"Suppl 1","key":"60214_CR32","first-page":"56S","volume":"45","author":"G Antoch","year":"2004","unstructured":"Antoch, G., Freudenberg, L. S., Beyer, T., Bockisch, A. & Debatin, J. F. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET\/CT. J. Nucl. Med. 45 (Suppl 1), 56S\u201365S (2004).","journal-title":"J. Nucl. Med."},{"key":"60214_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid, M. E. et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J. Clin. Oncol. 25, 571\u2013578 (2007).","journal-title":"J. Clin. Oncol."},{"key":"60214_CR34","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1182\/bloodadvances.2023010024","volume":"7","author":"EAM Zijtregtop","year":"2023","unstructured":"Zijtregtop, E. A. M. et al. Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH. Blood Adv. 7, 6303\u20136319 (2023).","journal-title":"Blood Adv."},{"key":"60214_CR35","doi-asserted-by":"publisher","first-page":"e232558","DOI":"10.1148\/radiol.232558","volume":"310","author":"AA Bankier","year":"2024","unstructured":"Bankier, A. A. et al. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 310, e232558 (2024).","journal-title":"Radiology"},{"key":"60214_CR36","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","volume":"28","author":"C Mauz-K\u00f6rholz","year":"2010","unstructured":"Mauz-K\u00f6rholz, C. et al. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin\u2019s lymphoma: the GPOH-HD-2002 study. J. Clin. Oncol. 28, 3680\u20133686 (2010).","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 1","key":"60214_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/annonc\/13.S1.75","volume":"13","author":"D Hasenclever","year":"2002","unstructured":"Hasenclever, D. The disappearance of prognostic factors in Hodgkin\u2019s disease. Ann. Oncol. 13 (Suppl 1), 75\u201378 (2002).","journal-title":"Ann. Oncol."},{"key":"60214_CR38","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1080\/10428194.2021.1881515","volume":"62","author":"SA Milgrom","year":"2021","unstructured":"Milgrom, S. A., Dabaja, B. S. & Mikhaeel, N. G. Advanced-stage Hodgkin lymphoma: have effective therapy and modern imaging changed the significance of bulky disease? Leuk. Lymphoma. 62, 1554\u20131562 (2021).","journal-title":"Leuk. Lymphoma"},{"key":"60214_CR39","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever, D. & Diehl, V. A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N Engl. J. Med. 339, 1506\u20131514 (1998).","journal-title":"N Engl. J. Med."},{"key":"60214_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/0360-3016(83)90317-6","volume":"9","author":"RA Rostock","year":"1983","unstructured":"Rostock, R. A., Siegelman, S. S., Lenhard, R. E., Wharam, M. D. & Order, S. E. Thoracic CT scanning for mediastinal Hodgkin\u2019s disease: Results and therapeutic implications. Int. J. Radiat. Oncol. Biol. Phys. 9, 1451\u20131457 (1983).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"60214_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1148\/radiology.160.3.3737899","volume":"160","author":"RA Castellino","year":"1986","unstructured":"Castellino, R. A., Blank, N., Hoppe, R. T. & Cho, C. Hodgkin disease: contributions of chest CT in the initial staging evaluation. Radiology 160, 603\u2013605 (1986).","journal-title":"Radiology"},{"key":"60214_CR42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2214\/ajr.156.4.2003430","volume":"156","author":"ER Lewis","year":"1991","unstructured":"Lewis, E. R., Caskey, C. I. & Fishman, E. K. Lymphoma of the lung: CT findings in 31 patients. Am. J. Roentgenol. 156, 711\u2013714 (1991).","journal-title":"Am. J. Roentgenol."},{"key":"60214_CR43","first-page":"507","volume":"113","author":"SJ Mentzer","year":"1993","unstructured":"Mentzer, S. J., Reilly, J. J., Skarin, A. T. & Sugarbaker, D. J. Patterns of lung involvement by malignant lymphoma. Surgery 113, 507\u2013514 (1993).","journal-title":"Surgery"},{"key":"60214_CR44","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s003300100866","volume":"11","author":"S Diederich","year":"2001","unstructured":"Diederich, S. et al. Pulmonary manifestations of Hodgkin\u2019s disease: radiographic and CT findings. Eur. Radiol. 11, 2295\u20132305 (2001).","journal-title":"Eur. Radiol."},{"key":"60214_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/hon.3163_34","volume":"41","author":"D Casey","year":"2023","unstructured":"Casey, D. et al. Patterns of presentation and outcomes in stage iv Hodgkin lymphoma: A report from the children\u2019s oncology group (cog) ahod1331 trial. Hematol. Oncol. 41, 69\u201369 (2023).","journal-title":"Hematol. Oncol."},{"key":"60214_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0022-3468(92)90336-6","volume":"27","author":"NS Rosenfield","year":"1992","unstructured":"Rosenfield, N. S., Keller, M. S., Markowitz, R. I., Touloukian, R. & Seashore, J. CT differentiation of benign and malignant lung nodules in children. J. Pediatr. Surg. 27, 459\u2013461 (1992).","journal-title":"J. Pediatr. Surg."},{"key":"60214_CR47","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2214\/AJR.09.2490","volume":"194","author":"CT Silva","year":"2010","unstructured":"Silva, C. T., Amaral, J. G., Moineddin, R., Doda, W. & Babyn, P. S. CT characteristics of lung nodules present at diagnosis of extrapulmonary malignancy in children. AJR Am. J. Roentgenol. 194, 772\u2013778 (2010).","journal-title":"AJR Am. J. Roentgenol."},{"key":"60214_CR48","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.acra.2009.06.008","volume":"16","author":"MH Kallenberg","year":"2009","unstructured":"Kallenberg, M. H. et al. Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies. Acad. Radiol. 16, 1408\u20131415 (2009).","journal-title":"Acad. Radiol."},{"key":"60214_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-024-05859-y","author":"D Stoevesandt","year":"2024","unstructured":"Stoevesandt, D. et al. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging. Pediatr. Radiol. https:\/\/doi.org\/10.1007\/s00247-024-05859-y (2024).","journal-title":"Pediatr. Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60214-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:03:01Z","timestamp":1783335781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60214"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60214-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20759"}}